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Abstract
Phosphoinositide 3-kinase (PI3K) signaling in hypothalamic neurons integrates peripheral metabolic cues, including
leptin and insulin, to coordinate systemic glucose and energy homeostasis. PI3K is composed of different subunits,
each of which has several unique isoforms. However, the role of the PI3K subunits and isoforms in the ventromedial
hypothalamus (VMH), a prominent site for the regulation of glucose and energy homeostasis, is unclear. Here we
investigated the role of subunit p110β in steroidogenic factor-1 (SF-1) neurons of the VMH in the regulation of
metabolism. Our data demonstrate that the deletion of p110β in SF-1 neurons disrupts glucose metabolism, rendering
the mice insulin resistant. In addition, the deletion of p110β in SF-1 neurons leads to the whitening of brown adipose
tissues and increased susceptibility to diet-induced obesity due to blunted energy expenditure. These results highlight
a critical role for p110β in the regulation of glucose and energy homeostasis via VMH neurons.
Introduction
Obesity and obesity-related metabolic diseases are
major public health burdens1. The central nervous system
(CNS) governs whole-body metabolism by sensing and
responding to fluctuating levels of circulating cues, such
as nutrients and hormones. Unraveling the neuronal
mechanisms by which the CNS regulates metabolism is a
fundamental step in the treatment of metabolic disease
and recent scientific efforts in this area have led to a new
class of Food and Drug Administration-approved anti-
obesity drugs2.
The hypothalamus is an important region for the reg-
ulation of metabolism3. In particular, the ventral medial
nucleus of the hypothalamus (VMH) has been known
since the early 1940s, to play a critical role in the reg-
ulation of glucose and energy balance4,5. However, the
molecular blueprint underlying the VMH regulation of
glucose and energy homeostasis remains unclear. Phos-
phoinositide 3-kinase (PI3K) is critical for the integration
of metabolic hormone cues. It is composed of the reg-
ulatory subunit p85 and the catalytic subunit p110, and
each subunit comprised several variant forms. Previously,
we demonstrated that mice lacking p110α in the VMH are
more prone to high-fat diet (HFD)-induced obesity and
obesity-related metabolic disturbances6. Recent studies
have shown distinct metabolic roles for each subunit/
variant in proopiomelanocortin (POMC) and agouti-
related peptide (AgRP) neurons of the arcuate nucleus
(ARC) of the hypothalamus7–9. These studies indicate
that, at least in ARC neurons, p110β plays a greater role in
the regulation of metabolism than does p110α. Although
electrophysiological approaches suggest that p110β is
required for leptin and insulin action in the VMH10, the
specific metabolic roles of each of the PI3K subunits in
VMH neurons are not well understood. Here we investi-
gated the role of p110β in the VMH in the regulation of
glucose and energy metabolism.
© The Author(s) 2019
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Ki Woo Kim (KIWOO-KIM@yuhs.ac)
1Division of Hypothalamic Research, Department of Internal Medicine, UT
Southwestern Medical Center, Dallas, TX 75390, USA
2Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX
75390, USA
Full list of author information is available at the end of the article.
These authors contributed equally: Teppei Fujikawa, Yun-Hee Choi



































Animal care and generation of tissue-specific KO mice
All experimental procedures were approved by the
Institutional Animal Care and Use Committees at
UT Southwestern (Dallas, TX) and Yonsei University
College of Medicine. Mice were kept at room temperature
(22 °C–24 °C) with a 12 h light/dark cycle (lights on at
06:00 h) and fed a normal mouse chow diet (4% fat diet;
7001; Harlan Laboratories) or a HFD (Research Diet
#D12331; 58% kcal from fat, 26% from sucrose, 5.56 kcal/
g) with water provided ad libitum. To generate VMH-
specific p110β knockout (KO) (p110β KOsf1) mice, males
that were homozygous for the floxed (F) p110β allele11 and
heterozygous for the Sf-1-Cre transgene12 were crossed
with female mice homozygous for the floxed p110β allele.
Littermate mice homozygous for the floxed p110β allele
(p110βF/F) served as controls (Ctr). All experimental mice
were on a mixed C57BL/6;129S6/SvEv background.
Protein and mRNA analyses
All samples were collected between 1300 and 1500 h for
quantitative PCR (Q-PCR) analysis. Total RNA was iso-
lated using Trizol reagent (Invitrogen, Carlsbad, CA) and
reverse transcribed with a SuperScript First-Strand
Synthesis System (Invitrogen) for reverse transcriptase
PCR (RT-PCR). Real-time PCR (Q-PCR) was performed
using an ABI 7900 HT Sequence Detection System
(Applied Biosystems, Foster City, CA). The Q-PCR pri-
mers used for the TaqMan method (Applied Biosystems)
are as follows: 18S (ABI, Hs99999901), pik3ca (ABI,
Mm00435673_m1), pik3cb (ABI, Mm00659576_m),
pik3r1 (ABI, Mm00808818_s1), pik3c2a (ABI,
Mm00478162_m1), β-adrenergic receptor 3 (β3-AR)
(ABI, Mm02601819_g1), Cidea (ABI, Mm00432554_m1),
PGC1α (ABI, Mm01208835_m1), PPARγ (ABI,
Mm01184322_m1), PRDM16 (ABI, Mm01266507_g1),
uncoupling protein 1 (UCP1) (ABI, Mm01244861), and
UCP3 (ABI, Mm01163394_m1).
For protein analysis, tissues from control and p110β
KOsf1 mice were homogenized in lysis buffer [20 mM Tris,
5 mM EDTA, and NP40 1% (v/v)] containing protease
inhibitors (P2714 Sigma, St. Louis, MO, resolved by SDS-
polyacrylamide gel electrophoresis and finally transferred
to a nitrocellulose membrane. After blocking the mem-
brane with 5% non-fat milk, proteins were detected using
the following commercially available antisera: UCP1
(Abcam, Cambridge, MA, 1:5000), GAPDH (Santa Cruz
Biotech, Santa Cruz, CA, 1:5000), phosphorylation of
AKT (pAKT) (Cell Signaling Technology, 1:2000), and
pFoxO1 (Cell Signaling Technology, 1:1000).
In situ hybridization
RNA in situ hybridization was performed on every
fourth serial section from the brains of control and p110β
KOsf1 mice13–17 (n= 5 for each genotype). Before hybri-
dization, brain sections were mounted onto SuperFrost
Plus slides (Fisher Scientific) and stored at −20 °C. Before
hybridization, sections were fixed in 4% formaldehyde for
20min, dehydrated in ascending concentrations of etha-
nol, cleared in xylene for 15 min, rehydrated in descend-
ing concentrations of ethanol, and placed in prewarmed
0.01M sodium citrate buffer pH 6.0. Sections were pre-
treated for 10min in a microwave, dehydrated in ethanol,
and air-dried. The p110β riboprobe was generated by
in vitro transcription with 35S-UTP. The 35S-labeled
probe was diluted (106 dpm/mL) in hybridization solu-
tion containing 50% formamide, 10% dextran sulfate, and
1× Denhardt’s solution (Sigma). The hybridization solu-
tion (120 µl) was applied to each slide and incubated
overnight at 56 °C. Sections were then treated with 0.002%
RNAase A solution and submitted to stringency washes in
decreasing concentrations of sodium chloride/sodium
citrate buffer. Sections were dehydrated and enclosed in
X-ray film cassettes with BMR-2 film (Kodak) for 72 h.
Slides were dipped into an NTB2 autoradiographic
emulsion (Kodak), dried, and stored at 4 °C for 25 days.
Slides were developed with a D-19 developer (Kodak).
The p110β probe was produced from PCR fragments
amplified with ExTaq DNA polymerase (Takara) from
cDNA generated with SuperScript II Reverse Tran-
scriptase (Invitrogen) for RT-PCR from total mouse
hypothalamic RNA. The p110β probe comprises positions
502–762 of the NCBI reference sequence NM_029094.3
and spans exon 4 of the Pik3cb gene. This region is
flanked by LoxP sites and, therefore, this probe can be
used to identify the Cre-mediated deletion of the Pik3cb
gene. All images were captured with a Nikon E1000
automated microscope installed with a Nikon digital
camera (DXM 1200F; Nikon, Melville, NY).
Metabolic cage studies
A combined indirect calorimetry system (CaloSys
Calorimetry System, TSE Systems, Inc., Bad Homburg,
Germany) was used for all metabolic studies. Experi-
mental animals were acclimated for 5 days in a home cage
with food and water. The room temperature for all
metabolic studies was maintained at 22 °C with a 12 h
light/dark cycle. Heat generation, O2 consumption, and
CO2 production were measured after acclimation, and the
relationship between metabolic rate and body mass was
normalized to metabolic body size (body weight 0.75)
unless otherwise noted. During this time, ambulatory and
rearing activities were also monitored with
infrared beams.
To assess diet-induced thermogenesis, chow-fed mice
with matched body weights were acclimatized in the TSE
metabolic chambers as described above, followed by
continuous monitoring of the metabolic rate. Chow was
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provided from day 1 to day 4 and replaced with a HFD at
17:00 h of day 4. Metabolic parameters were measured for
3 additional days. The ΔVO2 was calculated by the VO2
difference before and after the HFD.
Hormone measurement
Corticosterone levels were measured as previously
described6. Briefly, psychosocial stress was given to male
mice by housing for 30min in groups of four animals after
3 days of isolation. Trunk blood for corticosterone mea-
surements was taken by decapitation at the indicated
times (Supplementary Table 1). For follicle-stimulating
hormone (FSH), luteinizing hormone (LH), testosterone,
epinephrine, and norepinephrine measurements, serum
and/or plasma were obtained between 14:00 and 15:30 h.
The blood samples for corticosterone, FSH, LH, testos-
terone, epinephrine, and norepinephrine levels were sent
for analysis to either the Ligand Assay & Analysis Core at
the University of Virginia or the Hormone Assay &
Analytical Services Core, Vanderbilt Diabetes Research
and Training Center.
VMH dissection for western blotting and Q-PCR analyses
To assess leptin-mediated AKT and forkhead box-
containing protein of the O subfamily-1 (FoxO1) phos-
phorylation, body weight-matched 9- to 13-week-old male
mice were fasted for 18 h and given murine leptin (5 mg/
kg body weight, Sigma, St. Louis, MO) or pyrogen-free
saline (Sigma, St. Louis, MO). After 40 min, the animals
were transcardially perfused with 10% formalin. A coronal
slice between bregma −1.22 mm and −2.06 mm was
made, and then the VMH was microdissected with a
scalpel under a microscope. All samples were immediately
frozen on dry ice. Protein lysate was prepared from the
VMH sample and used for western blotting analysis as
described above.
To measure mRNA levels in the VMH of control and
p110β KOsf1 male mice, mice were decapitated after deep
anesthesia. The VMH was microdissected with a scalpel
under a microscope as described above. All samples were
immediately frozen on dry ice. Total mRNA was extracted
and used for Q-PCR analyses.
Histology
All tissues were fixed in 10% neutral buffered formalin
and either transferred to 1× phosphate-buffered saline
followed by paraffin embedding or cryoembedded after
sucrose infiltration for hematoxylin and eosin (H&E),
Nissl, pSTAT3, or Oil Red O staining.
Body weight and composition
The body weight of control and p110β KOsf1 mice fed a
normal chow diet (NCD) was monitored weekly from
weaning (4 weeks old) to 21 weeks. The body composition
of control and p110β KOsf1 mice was determined using a
Bruker Minispec mq10 nuclear magnetic resonance ana-
lyzer (The Woodlands, TX).
GTT and ITT
The glucose tolerance test (GTT) was performed as
previously described18. Male p110β KOsf1 mice and con-
trol littermates between the ages of 20–23 weeks were
fasted for 18 h with water provided ad libitum. After
fasted glucose levels were measured, glucose was admi-
nistered via intraperitoneal (i.p.) injection (1.5 g/kg body
weight). Blood glucose levels were measured from blood
sampled from tail nicks at 20, 40, 60, 90, and 120 min after
injection. Blood glucose levels were determined by the
glucose oxidase method using a commercial glucometer
(Ascensia Contour; Bayer HealthCare, Mishawaka, IN).
For the insulin tolerance test (ITT), male mice between
the ages of 20–23 weeks were fasted for 2 h with water
provided ad libitum. After measurements of basal glucose
levels, insulin (0.8 U/kg, Eli Lilly and Company, HI-210,
Indianapolis, IN) was administered via i.p. injection. Blood
glucose levels were monitored as described above.
Data analysis
The data are presented as the mean ± SEM, as indicated
in each figure legend. Statistical significance was deter-
mined by Student’s t-test or two-way analysis of variance.
GraphPad Prism, version 5.0a (GraphPad, San Diego, CA),
was used for all statistical analyses and P < 0.05 was
considered a statistically significant difference.
Results
Generation of SF-1 neuron (VMH)-specific p110β KO mice
p110β is ubiquitously expressed and mice lacking p110β
in the VMH were generated by crossing floxed p110β
mice11 with steroidogenic factor-1 (Sf-1) Cre mice (p110β
KOsf1)12, which in the CNS, express Cre recombinase
exclusively in the VMH. Histological analyses confirmed
that the deletion of p110β was confined to the VMH (Fig.
1a–d) without disturbing VMH cytoarchitecture (Sup-
plementary Fig. 1). Q-PCR analysis of RNA isolated from
the VMH showed that p110β was significantly reduced,
and that the expression of the remaining isoforms and
subunits was unchanged (Fig. 1e). Peripherally, SF-1 is
also expressed in the pituitary, adrenal glands, and
gonads, which are important tissues for the regulation of
metabolism. We therefore examined these tissues for
morphological changes and measured the circulating
levels of corticosterone (normal and stressed), testoster-
one, FSH, and LH. We found similar tissue morphology
and hormone parameters between the two genotypes,
indicating that the hypothalamic–pituitary–adrenal and
hypothalamic–pituitary–gonadal axes were intact (Sup-
plementary Fig. 2 and Supplementary Table 1). These data
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suggest that the metabolic phenotype of the p110β KOsf1
mice described in this study is not secondary to disrup-
tions in these hormones.
To determine whether the deletion of p110β in SF-1
neurons altered PI3K signaling in the VMH19, we mea-
sured the pAKT and FoxO1 in the VMH after intraper-
itoneal leptin administration (5 mg/kg). Although leptin
administration activated pAKT and pFoxO1 in the VMH
of control mice, this effect was significantly blunted in
mice that lacked p110β (Fig. 1f). In contrast, the activation
of pSTAT3 by leptin was comparable (Supplementary Fig.
3). These results indicate that p110β in SF-1 neurons of
the VMH is necessary for the normal activation of the
PI3K pathway.
p110β isoform in the VMH is required for normal glucose
homeostasis
To investigate the role of p110β in the regulation of
energy homeostasis, we first examined several metabolic
parameters in mice fed a NCD. No differences were
observed in body weight, body composition, leptin and
insulin levels, food intake, oxygen consumption (VO2),
locomotor activity, or respiratory exchange ratio (RER)
between littermate controls and p110β KOsf1 mice (Sup-
plementary Fig. 4). Numerous studies suggest that the
VMH is a key brain site for the regulation of glucose
homeostasis through the modulation of the autonomic
nervous system20–23. For instance, microinjection of lep-
tin or orexin into the VMH increases glucose uptake and
enhances insulin sensitivity, and VMH-mediated glucose
uptake is blocked by inhibition of the sympathetic nervous
system (SNS)24–26. Although we found no significant
differences in the glucose levels of mice fed a NCD, glu-
cose levels during the refeeding period following a 24 h
fast were significantly elevated in p110β KOsf1 mice
compared with control mice (Fig. 2a). Furthermore, p110β
KOsf1 mice exhibited blunted glucose and insulin sensi-
tivity in response to both i.p. GTTs and ITTs (Fig. 2b–f).
Notably, previous studies have shown that the deletion of
p110α in the VMH does not affect glucose metabolism in
NCD-fed mice6. Our data suggest that glucose home-
ostasis by SF-1 neurons in the VMH is uniquely mediated
by the p110β subunit.
Serum insulin levels obtained during the course of the
GTT were unaltered (Fig. 2d), suggesting an impairment
in insulin sensitivity rather than impaired insulin secre-
tion from pancreatic β-cells. Therefore, we measured
insulin sensitivity in peripheral tissues, including the liver,
interscapular brown adipose tissue (iBAT), heart, and
muscle, by monitoring the activation of pAKT after i.p.
injection of insulin27. The insulin-mediated activation of
pAKT was decreased in p110β KOsf1 mice in all tissues
examined, including the iBAT, heart, and muscle, com-
pared with control littermates (Fig. 2g–j). These results
strongly suggest that the blunted insulin sensitivity in
these peripheral tissues contributes to altered whole-body
glucose homeostasis in p110β KOsf1 mice.
Increased whitening of iBAT and decreased energy
expenditure in p110β KOsf1 mice
The VMH is a critical brain site mediating sympathetic





































Fig. 1 Deletion of p110β is restricted to SF-1 neurons of the VMH. Expression of p110β detected by RNA in situ hybridization in the anterior VMH
of a control and b p110β KOsf1 mice, and the posterior VMH of c control and d p110β KOsf1 mice. emRNA expression of p110β, p110α, p85α, and PI3K-
C2α in the VMH of control and p110β KOsf1 mice. f The VMH was collected after i.p. administration of leptin (5 mg/kg body weight) and the levels of
pAKT and pFoxO1 were measured in control and p110β KOsf1 mice. The number of mice in each group is indicated in the figure. *P < 0.05 by
Student’s t-test. Data are shown as mean ± SEM. Scale bar= 200 μm. Abbreviations: 3V, third ventricle; ARC, arcuate nucleus; Ctr, control; DMH,
dorsomedial nucleus of the hypothalamus
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signaling causes iBAT lipid accumulation30,31, a process
known as “whitening”31. Notably, the activation of pAKT
in the iBAT after insulin administration was significantly
blunted in p110β KOsf1 mice (Fig. 2h). H&E staining
revealed an increase in lipid droplets in p110β KOsf1 mice
(Fig. 3a–c). In addition, the RNA levels of β3-AR and
UCP1, and the protein levels of UCP1 were significantly
reduced in the iBAT of p110β KOsf1 mice (Fig. 3d–f).
Moreover, plasma norepinephrine, a neurotransmitter
released by sympathetic nerve terminals, was decreased in
p110β KOsf1 mice (Fig. 3g). Our study demonstrates that
the deletion of p110β in SF-1 neurons hampers sympa-
thetic activity and leads to the whitening of iBAT. Col-
lectively, these data suggest that p110β expression in the
VMH is a key module to maintain BAT programming.
As p110β KOsf1 mice displayed changes in sympathetic
tone, we postulated that metabolic stress would alter
metabolic homeostasis in p110β KOsf1 mice. Of note, a
HFD decreases UCP1, PGC1α, and other genes, which are
important for maintaining BAT programming31. To
address this hypothesis, metabolic stress was induced by
challenging mice with a HFD and assessing the metabolic
response of p110β KOsf1 mice. The body weight of p110β
KOsf1 mice began to diverge from that of control mice
after 6 weeks of HFD feeding (Fig. 4a). The increased body
weight was caused by increased fat mass but not lean mass
(Fig. 4b, c). Indirect calorimetry studies revealed sig-
nificantly decreased oxygen consumption in p110β KOsf1
mice, without changes in food intake, movement, or the
RER during HFD feeding (Fig. 4d–h). These data imply
that PI3K activity in SF-1 neurons of the VMH might be
necessary for the regulation of energy expenditure, espe-
cially under high-calorie conditions. Serum analysis
showed elevated levels of leptin, insulin, fasted glucose,
triglyceride (TG), and free fatty acid in HFD-fed p110β
KOsf1 mice (Fig. 4i–m). In addition, HFD-fed p110β KOsf1
mice exhibited increased liver TG (Fig. 4n) but not serum
or liver cholesterol (Fig. 4o, p). These results indicate that
the p110β subunit in the VMH might be involved in the
regulation of metabolic homeostasis.
Discussion
Although the metabolic importance of PI3K has been
shown in several tissues, little is known about its function
in the hypothalamus6,9,11. In this study, we specifically
deleted the p110β isoform of PI3K from SF-1 neurons of
the VMH. We found that p110β in the VMH, possibly
through actions on the autonomic nervous system, is
required for energy homeostasis and the maintenance of
normal glucose and insulin sensitivity. p110α and p110β
are class IA PI3K isoforms, and studies using global KO
mice have suggested that each isoform has distinct
metabolic functions32,33. Notably, the deletion of class I
PI3K isoforms in ARC POMC or AgRP neurons revealed
that p110β has a greater contribution than does p110α to
metabolic parameters, such as body weight, food intake,
and leptin-mediated neuronal excitability9,34. Our studies
have extended these findings to the VMH. We previously
Fig. 2 Deletion of p110β in SF-1 neurons disrupts glucose and insulin homeostasis. a Glucose levels in fed (3 h fasted), fasted (24 h), and refed
(1 h) male mice. b GTT [significant interaction (two-way repeated ANOVA, F5.62= 37.65, p < 0.0001)]. c Area under the curve (AUC) from b. d Insulin
levels during the GTT. e ITT [significant interaction (two-way repeated ANOVA, F1.66= 14.84, p= 0.00003)]. f Area under the curve (AUC) from e.
Blunted insulin-induced pAKT activation in the g liver, h iBAT, i heart, and j gastrocnemius muscle of p110β KOsf1 mice. Number of mice in each
group is indicated in the legends or directly in the figures. Data are shown as the mean ± SEM. *P < 0.05 by Student’s t-test
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showed that p110α deletions in the VMH affect diet-
induced obesity but not the basal metabolic rate6. Our
current study shows that p110β in SF-1 neurons of the
VMH plays a much broader role, affecting glucose and
insulin homeostasis and BAT function.
The VMH is well known to regulate many physiological
processes, including energy expenditure, reproduction,
defensive behavior, food intake, carbohydrate and fat
metabolism, and metabolic adaptation6,12,18,23,29,35–57. In
1966, Shimazu et al.35 demonstrated that electric stimu-
lation of the VMH remarkably increased blood glucose
and suggested the important role of the VMH in the
regulation of glucose metabolism56,57. Previous reports
have indicated that microinjection of leptin into the VMH
can stimulate glucose uptake into the peripheral tissues,
including skeletal muscle25. We recently found that the
p110β subunit is required for leptin-induced depolariza-
tion in SF-1 neurons of the VMH10. Collectively, these
studies suggest that the deletion of p110β in SF-1 neurons
may compromise leptin’s glucoregulatory actions, leading
to refractory responses to the GTT. Interestingly, we
found that p110β KOsf1 mice exhibited glucose intoler-
ance under refed conditions, with no significant body
weight change, and exhibited diet-induced obesity, with
significantly increased fasted glucose levels. p110β KOsf1
mice exhibited insulin insensitivity in the iBAT, heart, and
gastrocnemius muscle. These results highly imply that the
higher glucose level in p110β KOsf1 mice might be the
result of decreased glucose uptake and insulin sensitivity
mediated by decreased sympathetic tone.
A recent paper showed that SNS input is necessary for
maintaining the thermogenic properties of BAT31. Dis-
ruption of the SNS signaling pathway leads to a whitening
of BAT accompanied by a reduction in mitochondrial
activity and the accumulation of lipid droplets51. In fact,
ob/ob58 and DIO31 mice show impaired SNS and BAT
whitening. The VMH regulates BAT function via the
SNS24,25,36,41. Lesions in the VMH have been shown to
cause mitochondrial dysfunction and to reduce fatty acid
oxidation59–61, indicating that an intact VMH is impor-
tant for maintaining BAT function. Lower levels of nor-
epinephrine together with increased iBAT whitening in
p110β KOsf1 mice suggest that p110β in the VMH might
be a critical component for the SNS-mediated BAT
pathway, while further analyses including the direct
visualization of sympathetic nerve fibers are necessary.
Our study supports the notion that the VMH plays a




































































































































p110β KO    (7)sf1
Fig. 3 Deletion of p110β in SF-1 neurons leads to the whitening of iBAT. a Hematoxylin and eosin staining of iBAT from control and p110β KOsf1
mice. b Distribution (% of population) of lipid droplets from a [significant interaction (two-way ANOVA, F1.20= 18.02, p= 0.0001)]. c Mean lipid area
(μm2) of the droplets from a. d mRNA levels of genes in iBAT regulating BAT programming. e UCP1 protein levels in the iBAT of control and p110β
KOsf1 mice. f Average UCP1 protein levels in the iBAT of control and p110β KOsf1 mice. g Plasma norepinephrine and epinephrine levels in chow-fed
males. Number of mice in each group is indicated in the legends or directly in the figures. Data are shown as the mean ± SEM. *P < 0.05 by Student’s
t-test. EPI, epinephrine; Ctr, control; NE, norepinephrine
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conditions requiring high-energy expenditure, such as a
HFD and exercise6,12,48,50,53,55,62. The regulation of energy
expenditure by the VMH is known to be mediated by the
SNS; however, the precise neuronal pathway linking the
SNS and the VMH has not yet been precisely determined.
Genetic tracing experiments revealed that SF-1 neurons
project to several brain nuclei that regulate SNS func-
tion63; thus, future studies using emerging techniques
such as channel rhodopsin-assisted neurocircuit map-
ping64 may provide further insights into the functional
pathways linking the SNS and the VMH. In summary, the
current study suggests that pharmaceutical therapies that
target PI3K in a tissue- and isoform-specific manner may
prove beneficial toward ameliorating metabolic syndrome,
especially diabetes.
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